Global Prenatal Testing and Newborn Screening Service Market Growth (Status and Outlook) 2025-2031

The global Prenatal Testing and Newborn Screening Service market size is predicted to grow from US$ 7753 million in 2025 to US$ 17490 million in 2031; it is expected to grow at a CAGR of 14.5% from 2025 to 2031.

Prenatal testing and newborn screening are effective methods for early detection of genetic metabolic diseases.

Rapidly growing global population, rising adoption rate of obstetric testing equipment in clinics, rapid development of modern healthcare, and continuous regulation across the healthcare industry are the key factors driving the growth of prenatal testing and newborn screening services market revenue.

ReportPrime newest research report, the “Prenatal Testing and Newborn Screening Service Industry Forecast” looks at past sales and reviews total world Prenatal Testing and Newborn Screening Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Prenatal Testing and Newborn Screening Service sales for 2025 through 2031.

This Insight Report provides a comprehensive analysis of the global Prenatal Testing and Newborn Screening Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

This report also analyses the strategies of leading global companies with a focus on Prenatal Testing and Newborn Screening Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prenatal Testing and Newborn Screening Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prenatal Testing and Newborn Screening Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prenatal Testing and Newborn Screening Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Prenatal Testing and Newborn Screening Service market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Intrusive
• Non-Invasive

Segmentation by Application:

• Hospital
• Diagnostic Center
• Others

Market by Region:

• Americas
• APAC
• Europe
• Middle East & Africa

Company Overview:

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• PerkinElmer
• Natera
• Invitae
• Centogene
• Illumina
• Natus Medical
• Sequenom
• Cradle Genomics
• Hoffmann-La Roche
• Quest Diagnostics
• Baebies
• Ravgen
• Eurofins Scientific
• BGI Genomics
• Shanghai Biotecan Pharmaceuticals Corporation
• Annaroad Gene
• Guangzhou Darui Biotechnology
• Beijing Berry Genomics

Key Questions Addressed in this Report